Endoglin in African children with plasmodium falciparum malaria: A novel player in severe malaria pathogenesis?

Journal of Infectious Diseases

Volumn 200, Issue 12, 2009, Pages 1842-1848

  Dietmann, Anelia ^a,c   Helbok, Raimund ^a,c   Lackner, Peter ^a   Fischer, Marlene ^a   Reindl, Markus ^a   Lell, Bertrand ^b,c   Issifou, Saadou ^b,c   Kremsner, Peter G ^b,c   Schmutzhard, Erich ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ALBERT SCHWEITZER HOSPITAL   (Gabon)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA;

AFRICA; ARTICLE; BRAIN MALARIA; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GABON; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

AFRICA; ANIMALS; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFLAMMATION; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX;

EID: 71949105069     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/648476     Document Type: Article

References (50)

1. World Health Organization. World malaria report 2008. Available at: http://apps.who.int/malaria/wmr2008/. Accessed 4 May 2009.
2. Coltel N, Combes V, Hunt NH, Grau GE. Cerebral malaria - a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res 2004; 1:91-110.
3. 3. Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int J Parasitai 2006; 36:555-568 (Pubitemid 43674514)
4. Peters CJ, Zaki SR. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med 2002; 30:S268-73.
5. Schouten M, Wiersinga WJ, Levi M, van der PT. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83:536-545
6. Wassmer SC, Combes V, Candal FJ, Juhan-Vague I, Grau GE. Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun 2006; 74:645-653
7. 7. Wassmer SC, de Souza JB, Frere C, Candal FJ, Juhan-Vague I, Grau GE. TGF-betal released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. J Immunol 2006; 176:1180-1184 (Pubitemid 43099721)
8. 8. Chaiyaroj SC, Rutta AS, Muenthaisong K, Watkins P, Na UM, Looareesuwan S. Reduced levels of transforming growth factor-betal, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. Acta Trop 2004; 89:319-327 (Pubitemid 38117068)
9. Wenisch C, Parschalk B, Burgmann H, Looareesuwan S, Graninger W Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum malaria. J Clin Immunol 1995; 15:69-73.
10. Omer FM, Kurtzhals JA, Riley EM. Maintaining the immunological balance in parasitic infections: a role for TGF-beta? Parasital Today 2000; 16:18-23.
11. DiChiara MR, Kiely JM, Gimbrone MA, Jr., Lee ME, Perrella MA, Topper JN. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J Exp Med 2000; 192:695-704.
12. Park SK, Yang WS, Lee SK, et al. TGF-beta(1) down-regulates inflammatory cytokine-induced VCAM-1 expression in cultured human glomerular endothelial cells. Nephrol Dial Transplant 2000; 15:596-604.
13. 13. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425:577-584 (Pubitemid 37280136)
14. ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004; 29:265-273
15. Lebrin F, Deckers M, Bertolino P, ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovasc Res 2005; 65:599-608.
16. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002; 21:1743-1753
17. 17. Lebrin F, Goumans MJ, Jonker L, et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 2004; 23:4018-4028 (Pubitemid 39472423)
18. Cheifetz S, Bellon T, Cales C, et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992; 267:19027-19030
19. 19. Fonsatti E, Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2004; 2:18. (Pubitemid 39130354)
20. 20. Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 1990; 265:8361-8364 (Pubitemid 20167332)
21. 21. Miller DW, Graulich W, Karges B, et al. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 1999;81:568-572 (Pubitemid 29203054)
22. 22. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17:984-992 (Pubitemid 36676386)
23. 23. Li C, Issa R, Kumar P, et al. CD 105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci. 2003; 116:2677-2685 (Pubitemid 36857221)
24. 24. Velasco-Loyden G, Arribas J, Lopez-Casillas F. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J Biol Chem 2004; 279:7721-7733 (Pubitemid 38294655)
25. 25. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005. (Pubitemid 44343543)
26. 26. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S. CD105 antagonizes the inhibitory signaling of transforming growth factor betal on human vascular endothelial cells. FASEB J 2000; 14: 55-64. (Pubitemid 30051523)
27. 27. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-649 (Pubitemid 43865232)
28. Sylla EH, Kun JF, Kremsner PG. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Trans R Soc Trop Med Hyg 2000; 94:652-656
29. Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH. Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop Med Parasitai 1995; 46:77-82.
30. World Health Organisation (WHO). Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;94(Suppl 1):1-90.
31. Helbok R, Dent W, Nacher M, et al. The use of the multi-organdysfunction score to discriminate different levels of severity in severe and complicated Plasmodium falciparum malaria. Am J Trop Med Hyg 2005; 72:150-154
32. Helbok R, Issifou S, Matsiegui PB, et al. Simplified multi-organ dysfunction score predicts disability in African children with Plasmodium falciparum malaria. Am J Trop Med Hyg 2006; 75:443-447
33. 33. Planche T, Krishna S, Kombila M, et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 2001; 65:599-602. (Pubitemid 33134599)
34. Faille D, Combes V, Mitchell AJ, et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J 2009; 23:3449-3458
35. Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D'Amore PA. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS ONE 2009; 4:e5149.
36. 36. Beare NA, Taylor TE, Harding SP, Lewallen S, Molyneux ME. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 2006; 75:790-797 (Pubitemid 351627520)
37. Mishra SK, Newton CR. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 2009; 5:189-198
38. 38. Dondorp AM, Ince C, Charunwatthana P, et al. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis 2008; 197:79-84. (Pubitemid 351263470)
39. 39. Penet MF, Viola A, Confort-Gouny S, et al. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosc 2005; 25:7352-7358 (Pubitemid 41129807)
40. 40. Warrell DA, White NJ, Veall N, et al. Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human cerebral malaria. Lancet 1988; 2:534-538 (Pubitemid 18213846)
41. Dietmann A, Lackner P, Helbok R, et al. Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J 2008; 7:253.
42. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1999; 1411:217-230
43. 43. Laroux FS, Lefer DJ, Kawachi S, et al. Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal 2000; 2:391-396 (Pubitemid 30809304)
44. Dhangadamajhi G, Mohapatra BN, Kar SK, Ranjit MR. Endothelial nitric oxide synthase (eNOS) gene polymorphisms and P falciparum infection in Indian adults. Infect Immun 2009; 77:2943-2947
45. 45. Fernandez L, Garrido-Martin EM, Sanz-Rodriguez F, et al. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia. Hum Mol Genet 2007; 16:1515-1533 (Pubitemid 47050666)
46. Dietmann A, Helbok R, Lackner P, et al. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are assodated with disease severity. J Infect Dis 2008; 197:1614-1620
47. 47. Combes V, Taylor TE, Juhan-Vague I, et al. Circulating endothelial micropartides in malawian children with severe faldparum malaria complicated with coma. JAMA 2004; 291:2542-2544 (Pubitemid 38702769)
48. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003; 1:1655-1662
49. 49. Coltel N, Combes V, Wassmer SC, Chimini G, Grau GE. Cell vesiculation and immunopathology: implications in cerebral malaria. Microbes Infect 2006; 8:2305-2316 (Pubitemid 44322058)
50. Helbok R, Dent W, Nacher M, et al. Use of the multi-organ dysfunction score as a tool to discriminate different levels of severity in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 2003; 68:372-375